affinity laboratories limited
affinity laboratories limited Company Information
Company Number
10566588
Website
-Registered Address
cumberland house (suite 602), 80 scrubs lane, london, NW10 6RF
Industry
Research and experimental development on biotechnology
Telephone
02080901307
Next Accounts Due
December 2024
Group Structure
View All
Shareholders
christopher moriarty 58.6%
map (ni) ltd 25%
View Allaffinity laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of AFFINITY LABORATORIES LIMITED at £2.7m based on a Turnover of £2.3m and 1.15x industry multiple (adjusted for size and gross margin).
affinity laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of AFFINITY LABORATORIES LIMITED at £0 based on an EBITDA of £-113.7k and a 4.86x industry multiple (adjusted for size and gross margin).
affinity laboratories limited Estimated Valuation
Pomanda estimates the enterprise value of AFFINITY LABORATORIES LIMITED at £0 based on Net Assets of £-478.3k and 2.15x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Affinity Laboratories Limited Overview
Affinity Laboratories Limited is a live company located in london, NW10 6RF with a Companies House number of 10566588. It operates in the research and experimental development on biotechnology sector, SIC Code 72110. Founded in January 2017, it's largest shareholder is christopher moriarty with a 58.6% stake. Affinity Laboratories Limited is a young, small sized company, Pomanda has estimated its turnover at £2.3m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Affinity Laboratories Limited Health Check
Pomanda's financial health check has awarded Affinity Laboratories Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 5 areas for improvement. Company Health Check FAQs
3 Strong
3 Regular
5 Weak
Size
annual sales of £2.3m, make it smaller than the average company (£3.3m)
- Affinity Laboratories Limited
£3.3m - Industry AVG
Growth
3 year (CAGR) sales growth of 13%, show it is growing at a similar rate (13.1%)
- Affinity Laboratories Limited
13.1% - Industry AVG
Production
with a gross margin of 53%, this company has a comparable cost of product (53%)
- Affinity Laboratories Limited
53% - Industry AVG
Profitability
an operating margin of -8% make it less profitable than the average company (0.1%)
- Affinity Laboratories Limited
0.1% - Industry AVG
Employees
with 15 employees, this is below the industry average (42)
15 - Affinity Laboratories Limited
42 - Industry AVG
Pay Structure
on an average salary of £71.1k, the company has an equivalent pay structure (£71.1k)
- Affinity Laboratories Limited
£71.1k - Industry AVG
Efficiency
resulting in sales per employee of £156.2k, this is more efficient (£131.2k)
- Affinity Laboratories Limited
£131.2k - Industry AVG
Debtor Days
it gets paid by customers after 75 days, this is later than average (51 days)
- Affinity Laboratories Limited
51 days - Industry AVG
Creditor Days
its suppliers are paid after 198 days, this is slower than average (59 days)
- Affinity Laboratories Limited
59 days - Industry AVG
Stock Days
it holds stock equivalent to 27 days, this is less than average (55 days)
- Affinity Laboratories Limited
55 days - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Affinity Laboratories Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 151%, this is a higher level of debt than the average (49.8%)
151% - Affinity Laboratories Limited
49.8% - Industry AVG
AFFINITY LABORATORIES LIMITED financials
Affinity Laboratories Limited's latest turnover from March 2023 is estimated at £2.3 million and the company has net assets of -£478.3 thousand. According to their latest financial statements, Affinity Laboratories Limited has 15 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Turnover | ||||||
| Other Income Or Grants | ||||||
| Cost Of Sales | ||||||
| Gross Profit | ||||||
| Admin Expenses | ||||||
| Operating Profit | ||||||
| Interest Payable | ||||||
| Interest Receivable | ||||||
| Pre-Tax Profit | ||||||
| Tax | ||||||
| Profit After Tax | ||||||
| Dividends Paid | ||||||
| Retained Profit | ||||||
| Employee Costs | ||||||
| Number Of Employees | 15 | 15 | 10 | 8 | 4 | |
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Tangible Assets | 197,023 | 258,657 | 141,738 | 61,867 | 63,947 | 80,646 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 102 | 102 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 197,125 | 258,759 | 141,738 | 61,867 | 63,947 | 80,646 |
| Stock & work in progress | 83,255 | 57,545 | 49,377 | 0 | 0 | 0 |
| Trade Debtors | 487,127 | 635,999 | 429,632 | 425,868 | 354,329 | 38,750 |
| Group Debtors | 25,806 | 20,555 | 12,216 | 0 | 0 | 0 |
| Misc Debtors | 143,606 | 189,476 | 243,019 | 0 | 0 | 69,186 |
| Cash | 0 | 36,508 | 157,053 | 22,680 | 0 | 70,624 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 |
| total current assets | 739,794 | 940,083 | 891,297 | 448,548 | 354,329 | 178,560 |
| total assets | 936,919 | 1,198,842 | 1,033,035 | 510,415 | 418,276 | 259,206 |
| Bank overdraft | 29,273 | 7,500 | 5,613 | 0 | 0 | 100,125 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 599,894 | 594,145 | 497,346 | 141,314 | 197,691 | 32,024 |
| Group/Directors Accounts | 100 | 100 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 216,524 | 418,767 | 231,091 | 0 | 0 | 80,657 |
| total current liabilities | 845,791 | 1,020,512 | 734,050 | 141,314 | 197,691 | 212,806 |
| loans | 301,238 | 313,333 | 257,720 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 0 | 0 | 0 | 0 | 0 | 0 |
| other liabilities | 268,186 | 123,077 | 3,077 | 350,000 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 569,424 | 436,410 | 260,797 | 350,000 | 0 | 0 |
| total liabilities | 1,415,215 | 1,456,922 | 994,847 | 491,314 | 197,691 | 212,806 |
| net assets | -478,296 | -258,080 | 38,188 | 19,101 | 220,585 | 46,400 |
| total shareholders funds | -478,296 | -258,080 | 38,188 | 19,101 | 220,585 | 46,400 |
| Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | |
|---|---|---|---|---|---|---|
| Operating Activities | ||||||
| Operating Profit | ||||||
| Depreciation | 73,887 | 71,665 | 29,587 | 22,153 | 11,436 | |
| Amortisation | 0 | 0 | 0 | 0 | 0 | |
| Tax | ||||||
| Stock | 25,710 | 8,168 | 49,377 | 0 | 0 | 0 |
| Debtors | -189,491 | 161,163 | 258,999 | 71,539 | 246,393 | 107,936 |
| Creditors | 5,749 | 96,799 | 356,032 | -56,377 | 165,667 | 32,024 |
| Accruals and Deferred Income | -202,243 | 187,676 | 231,091 | 0 | -80,657 | 80,657 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | ||||||
| Investing Activities | ||||||
| capital expenditure | ||||||
| Change in Investments | 0 | 102 | 0 | 0 | 0 | 0 |
| cash flow from investments | ||||||
| Financing Activities | ||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 100 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | -12,095 | 55,613 | 257,720 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 145,109 | 120,000 | -346,923 | 350,000 | 0 | 0 |
| share issue | ||||||
| interest | ||||||
| cash flow from financing | ||||||
| cash and cash equivalents | ||||||
| cash | -36,508 | -120,545 | 134,373 | 22,680 | -70,624 | 70,624 |
| overdraft | 21,773 | 1,887 | 5,613 | 0 | -100,125 | 100,125 |
| change in cash | -58,281 | -122,432 | 128,760 | 22,680 | 29,501 | -29,501 |
affinity laboratories limited Credit Report and Business Information
Affinity Laboratories Limited Competitor Analysis
Perform a competitor analysis for affinity laboratories limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.
affinity laboratories limited Ownership
AFFINITY LABORATORIES LIMITED group structure
Affinity Laboratories Limited has 3 subsidiary companies.
Ultimate parent company
AFFINITY LABORATORIES LIMITED
10566588
3 subsidiaries
affinity laboratories limited directors
Affinity Laboratories Limited currently has 2 directors. The longest serving directors include Mr Patrick McArdle (Dec 2017) and Mr Jonathan Shinton (Oct 2018).
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Patrick McArdle | Sweden | 53 years | Dec 2017 | - | Director |
| Mr Jonathan Shinton | 55 years | Oct 2018 | - | Director |
P&L
March 2023turnover
2.3m
-16%
operating profit
-187.6k
0%
gross margin
53%
+6.85%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
March 2023net assets
-478.3k
+0.85%
total assets
936.9k
-0.22%
cash
0
-1%
net assets
Total assets minus all liabilities
affinity laboratories limited company details
company number
10566588
Type
Private limited with Share Capital
industry
72110 - Research and experimental development on biotechnology
incorporation date
January 2017
age
7
accounts
Total Exemption Full
ultimate parent company
previous names
N/A
incorporated
UK
address
cumberland house (suite 602), 80 scrubs lane, london, NW10 6RF
last accounts submitted
March 2023
affinity laboratories limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to affinity laboratories limited. Currently there are 0 open charges and 2 have been satisfied in the past.
affinity laboratories limited Companies House Filings - See Documents
| date | description | view/download |
|---|
